(Q43918478)

28 November 2017

Therapeutic vaccination in chronic hepatitis B. (English)

1 reference

28 November 2017

1 reference

Hakan Senturk

1

1 reference

28 November 2017

Fehmi Tabak

2

1 reference

28 November 2017

Meral Akdogan

3

1 reference

28 November 2017

Levent Erdem

4

1 reference

28 November 2017

Ali Mert

5

1 reference

28 November 2017

Resat Ozaras

6

1 reference

28 November 2017

Ersan Sander

7

1 reference

28 November 2017

Gulsen Ozbay

8

1 reference

28 November 2017

Selim Badur

9

1 reference

28 November 2017

1 January 2002

1 reference

Journal of Gastroenterology and Hepatology

28 November 2017

1 reference

28 November 2017

17

1 reference

28 November 2017

1

1 reference

28 November 2017

72-76

1 reference

Placebo-controlled trial of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice

28 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02652.X

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02652.X

Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02652.X

Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02652.X

Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02652.X

Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02652.X

Spontaneous clearance and reactivation of hepatitis B virus infection among male homosexuals with chronic type B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02652.X

Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02652.X

Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02652.X

Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02652.X

Is there a causal link between hepatitis B vaccination and multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02652.X

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02652.X

10.1046/J.1440-1746.2002.02652.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference